Medicare Enrolled
Dr. Burhan Yanes, MD
Hematology & Oncology · Kettering, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yanes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yanes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yanes
Dr. Burhan Yanes is a hematology & oncology specialist in Kettering, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yanes performed 49,109 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Yanes received a total of $17,344 from 78 pharmaceutical and/or device companies across 341 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yanes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in OH
$17,344 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗49,109
Medicare services
Top 11% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,350 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 9,200 | $43 | $99 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,360 | $2 | $8 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,900 | $0 | $0 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,400 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 3,300 | $18 | $37 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,840 | $36 | $86 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,392 | $0 | $0 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,190 | $23 | $148 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,041 | $1 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
389 | $84 | $207 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
264 | $94 | $403 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
235 | $11 | $64 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
195 | $125 | $281 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
128 | $10 | $45 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
119 | $21 | $100 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
103 | $1 | $1 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
99 | $44 | $181 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
95 | $59 | $110 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
62 | $21 | $92 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
55 | $90 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
49 | $14 | $61 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
40 | $41 | $166 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
40 | $47 | $198 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
39 | $744 | $2,196 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 32 | $563 | $800 |
| New patient office visit, complex (60-74 min) | 29 | $147 | $402 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $64 | $140 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
21 | $65 | $192 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $127 | $399 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
19 | $22 | $84 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
18 | $84 | $470 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
16 | $2 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $89 | $320 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
13 | $146 | $484 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $209 | $448 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.9% high complexity
93.2% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,344
Total received (2018-2024)
Avg $2,478/year across 7 years
Top 22% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
341
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,957
2023
$1,932
2022
$2,705
2021
$1,888
2020
$154
2019
$486
2018
$7,223
Payments by company (2024)
Daiichi Sankyo Inc.
$561
AstraZeneca Pharmaceuticals LP
$528
Janssen Biotech, Inc.
$235
GlaxoSmithKline, LLC.
$194
ABBVIE INC.
$171
Merck Sharp & Dohme LLC
$148
Celgene Corporation
$115
Novartis Pharmaceuticals Corporation
$113
Takeda Pharmaceuticals U.S.A., Inc.
$111
EMD Serono, Inc.
$77
Gilead Sciences, Inc.
$63
Incyte Corporation
$46
Octapharma USA, Inc.
$38
Stemline Therapeutics Inc.
$37
Immunocore Limited
$36
TAIHO ONCOLOGY, INC.
$35
Genentech USA, Inc.
$35
Astellas Pharma US Inc
$34
E.R. Squibb & Sons, L.L.C.
$33
Pharmacosmos Therapeutics Inc.
$25
Lilly USA, LLC
$24
Mirati Therapeutics, Inc.
$22
BeiGene USA, Inc.
$21
PharmaEssentia USA Corporation
$20
Exelixis Inc.
$19
Fennec Pharmaceuticals, Inc.
$19
Alexion Pharmaceuticals, Inc.
$19
Sumitomo Pharma America, Inc.
$19
PFIZER INC.
$19
Adaptive Biotechnologies Corporation
$17
Legend Biotech USA Inc.
$17
Deciphera Pharmaceuticals Inc.
$17
Rigel Pharmaceuticals, Inc.
$16
Sirtex Medical Inc
$16
Ipsen Biopharmaceuticals, Inc
$16
Tempus AI, Inc
$15
Amneal Pharmaceuticals LLC
$13
IMMUNITYBIO, INC.
$13
Top 3 companies account for 44.8% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$3,564
GENZYME CORPORATION
$3,317
Seattle Genetics, Inc.
$2,496
Puma Biotechnology, Inc.
$1,106
Daiichi Sankyo Inc.
$711
AstraZeneca Pharmaceuticals LP
$636
Novartis Pharmaceuticals Corporation
$513
Merck Sharp & Dohme LLC
$460
Janssen Biotech, Inc.
$333
Celgene Corporation
$318
GlaxoSmithKline, LLC.
$243
Takeda Pharmaceuticals U.S.A., Inc.
$231
Incyte Corporation
$225
Astellas Pharma US Inc
$172
ABBVIE INC.
$171
E.R. Squibb & Sons, L.L.C.
$147
Amgen Inc.
$146
PFIZER INC.
$117
EMD Serono, Inc.
$108
Regeneron Healthcare Solutions, Inc.
$106
Karyopharm Therapeutics Inc.
$95
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Kite Pharma, Inc.
$89
EISAI INC.
$87
Eisai Inc.
$86
Ipsen Biopharmaceuticals, Inc
$83
Bayer Healthcare Pharmaceuticals Inc.
$81
Octapharma USA, Inc.
$76
TG THERAPEUTICS, INC.
$76
Myriad Genetic Laboratories, Inc.
$70
Rigel Pharmaceuticals, Inc.
$69
Genentech USA, Inc.
$68
Lilly USA, LLC
$60
Seagen Inc.
$59
Stemline Therapeutics Inc.
$55
TAIHO ONCOLOGY, INC.
$53
Foundation Medicine, Inc.
$51
Lexicon Pharmaceuticals, Inc.
$51
Bayer HealthCare Pharmaceuticals Inc.
$50
BeiGene USA, Inc.
$49
Mirati Therapeutics, Inc.
$43
PharmaEssentia USA Corporation
$39
Array BioPharma Inc.
$38
Immunocore Limited
$36
Genmab U.S., Inc.
$34
Deciphera Pharmaceuticals Inc.
$34
Alexion Pharmaceuticals, Inc.
$32
Sumitomo Pharma America, Inc.
$32
MorphoSys, US Inc.
$30
Cardinal Health 108, LLC
$26
Pharmacosmos Therapeutics Inc.
$25
Janssen Scientific Affairs, LLC
$24
Merck Sharp & Dohme Corporation
$23
Verastem, Inc.
$22
Aadi Bioscience, Inc.
$22
Apellis Pharmaceuticals, Inc.
$20
Exelixis Inc.
$19
Fennec Pharmaceuticals, Inc.
$19
Clovis Oncology, Inc.
$19
Mylan Institutional Inc.
$18
Pharmacyclics LLC, an AbbVie Company
$18
Tolmar, Inc.
$18
Adaptive Biotechnologies Corporation
$17
Legend Biotech USA Inc.
$17
SOBI, INC
$17
ADC Therapeutics America, Inc.
$16
Kyowa Kirin, Inc.
$16
Sirtex Medical Inc
$16
Heron Therapeutics, Inc.
$16
Tempus AI, Inc
$15
CTI BioPharma Corp.
$15
SERVIER PHARMACEUTICALS LLC
$15
Sun Pharmaceutical Industries Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$14
Amneal Pharmaceuticals LLC
$13
IMMUNITYBIO, INC.
$13
Servier Pharmaceuticals LLC
$12
Tactile Systems Technology Inc
$11
Top 3 companies account for 54.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · ANKTIVA · ASPARLAS · AVASTIN · BAVENCIO · BESREMI · BRUKINSA · Balversa · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · Columvi · Copiktra · DARZALEX · Doptelet · ELIGARD · ELITEK · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · FLEXITOUCH · FOUNDATIONONE · FYARRO · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGIVRI · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PLUVICTO · PROMACTA · Pedmark · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TABRECTA · TASIGNA · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
40
County median income
$64,403
Nearest hospital to ZIP centroid (approximate)
MIAMI VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yanes is a mixed practice specialist, with above-average Medicare volume (top 11% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yanes experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Yanes performed 10,350 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yanes receive payments from pharmaceutical companies?
Yes. Dr. Yanes received a total of $17,344 from 78 companies across 341 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yanes's costs compare to other hematology & oncology specialists in Kettering?
Dr. Yanes's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yanes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Kettering
Browse hematology & oncology specialists in Kettering ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology